Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people starting Mounjaro notice side effects in the first few weeks, and most find they settle as the body adjusts. The most common are nausea, constipation, diarrhoea, and fatigue — typically peaking around a dose increase and easing within days to a couple of weeks. Mounjaro (tirzepatide) is a prescription-only medicine requiring clinical assessment before it can be prescribed; the full picture of what to expect matters as much as the results. The NHS tirzepatide medicines page sets out the recognised side effects alongside guidance on when they need attention. This page walks through what's common, what's uncommon, what tends to improve with time, and what should prompt you to seek help.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first pen (dosed at 2.5mg) exists largely to let your system get used to the medicine. The lower dose means fewer and milder side effects for most people, but it rarely means none at all. Nausea is the one our prescribers hear about most weeks: a low-grade queasiness after the injection that tends to arrive within a day or two and then gradually fades. Some people also notice loose stools, bloating, burping, or a noticeably reduced appetite. Fatigue and mild headaches are reported too, though less often.
These reactions are largely explained by how tirzepatide works: it slows gastric emptying, which changes how quickly food moves through the stomach. Your gut is doing something new, and it tells you so. The effect tends to be most pronounced with the first injection of any new dose, not throughout that entire four-week period.
Injection-site redness or mild soreness is also common at the start, particularly while you're still finding the right technique. Rotating between the abdomen, thigh, and upper arm helps. For a deeper look at the full range of effects people report, the overview of Mounjaro side effects covers them in more detail.
This is probably the question that comes up most when someone is approaching their first dose escalation. The honest answer: yes, many people find side effects briefly return or intensify when the dose goes up, then settle again over the following week or two. The pattern repeats with each step through the schedule.
What tends to happen is that nausea reappears, sometimes accompanied by vomiting or loose stools. Most people describe it as manageable rather than debilitating, especially if they adjust eating habits, smaller portions, lower-fat foods, eating slowly, and staying well hydrated all reduce the likelihood of a rough few days. Drinking plenty of water also matters because persistent vomiting or diarrhoea can lead to dehydration, which is harder to recover from if it takes hold.
If you want to understand the timing more precisely, how long before Mounjaro side effects start breaks down the typical window across the treatment schedule. What varies most between people is not whether they get side effects, but how long each episode lasts. The dose-increase pattern is worth knowing about before you get there, not after.
After the first month or two, the majority of people report that gastrointestinal side effects have quietened down meaningfully. This is well-documented in the clinical trial data from the SURMOUNT programme. Nausea, in particular, tends to move from a noticeable presence to an occasional background note, if it returns, it's usually brief.
Some effects are genuinely welcome. Reduced appetite, slower gastric emptying, and a changed relationship with food cravings are part of how the medicine supports weight loss, and for most people these persist throughout treatment in a way that feels manageable rather than uncomfortable. Energy levels often improve as weight reduces and blood glucose stabilises. If you're specifically interested in the side effects that come with Mounjaro's weight loss action, there is a dedicated page covering what people typically experience as the weight comes off. There's a separate page on the beneficial side effects of Mounjaro for people who want to understand those more fully.
One area some people notice change is hair. Temporary hair thinning is occasionally reported during significant weight loss with any method, not specifically from tirzepatide itself, it's typically a response to the physiological stress of rapid calorie reduction. If this is a concern, Mounjaro and hair loss covers what the evidence actually shows.
Most Mounjaro side effects are uncomfortable rather than dangerous. But some require prompt attention, and being clear about the difference is part of using this medicine safely. If you are unsure what to watch for, our guide to weight loss drug Mounjaro side effects sets out the full picture of what is considered normal and what warrants concern.
Seek urgent medical help (contact NHS 111, your GP urgently, or A&E if needed) if you experience:
Milder side effects that aren't resolving, or any question about whether to continue or adjust treatment, should go to your prescriber or aftercare team rather than wait. At nume, our clinical team is reachable seven days a week. You can also reach the team via our contact page. And if you're still weighing up whether Mounjaro is appropriate for you, our prescribers discuss suitability, your health history, and exactly what to expect as part of the free consultation, check your eligibility to get started.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.